Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study
Inagaki, Nobuya, MD, PhD, Atsumi, Yoshihito, MD, PhD, Oura, Tomonori, MSc, Saito, Hitoshi, PhD, Imaoka, Takeshi, MD, PhD
Published in Clinical therapeutics (01.09.2012)
Published in Clinical therapeutics (01.09.2012)
Get full text
Journal Article